ClinicalTrials.Veeva

Menu

Tolerance and Development of Healthy, Term Infants

Abbott logo

Abbott

Status and phase

Completed
Phase 2

Conditions

Healthy

Treatments

Other: Alternate protein infant formula
Other: Standard infant formula

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

To compare the tolerance and early bone status of healthy, term infants fed formulas during the first three months of life.

Enrollment

115 patients

Sex

All

Ages

1 to 8 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy term infants;
  • Age 0-8 days of age;
  • Exclusively formula fed;
  • No use of vitamin/mineral supplements.

Exclusion criteria

  • Maternal, fetal or perinatal medical history thought to have potential for negative effects on tolerance, growth or development.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

115 participants in 2 patient groups

Protein formula
Experimental group
Description:
Feed as per HCP direction
Treatment:
Other: Alternate protein infant formula
Standard infant formula
Active Comparator group
Description:
Feed as per HCP instructions
Treatment:
Other: Standard infant formula

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems